Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover Study

Clinical trial NCT06905483 · COMPLETED

Trial details

NCT number: NCT06905483
Sponsor: Thammasat University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

COPD Chronic Obstructive Pulmonary Disease (COPD)Small Airway Disease Triple Therapy Lung Function

Start date: 2025-04-01
Primary completion: 2025-12-31
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.